Podrobno

Protibakterijsko vrednotenje piperidinske in pirolidinske knjižnice spojin
ID Tadina, Lara (Avtor), ID Hrast Rambaher, Martina (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Golob, Majda (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (1,99 MB)
MD5: 0600C556439A6ECD23A558FB86C8B125

Izvleček
Po ocenah svetovne zdravstvene organizacije (SZO, angl. World Health Organization, WHO) je problem bakterijske odpornosti v humani medicini uvrščen med vodilne vzroke smrti pri ljudeh. Odpornost proti antibiotikom pospešuje predvsem njihova nepravilna in prekomerna uporaba. Učinkovine, ki zavirajo rast bakterij, delujejo bakteriostatično, druge pa povzročijo odmiranje bakterijskih celic in delujejo baktericidno. Pomembna lastnost idealnega antibiotika je njegova selektivna toksičnost, kar pomeni, da mora zavirati le rast bakterijske celice, pri tem pa ne sme škodovati gostitelju. Protibakterijske učinkovine delujejo po različnih mehanizmih delovanja. Povzročijo lahko inhibicijo sinteze celične stene, interakcije s plazemsko membrano, inhibicijo sinteze nukleinskih kislin, inhibicijo sinteze proteinov in inhibicijo celičnega metabolizma. Čeprav poznamo več mehanizmov delovanja antibiotikov, so bakterije sposobne razviti odpornost proti njim na več različnih načinov. Omejijo lahko prehajanje antibiotika v celico, spremenijo vezavno mesto tarče, onesposobijo delovanje antibiotika, s pomočjo izlivnih črpalk zmanjšajo njegovo koncentracijo v celici in tvorijo biofilme. V okviru magistrske naloge smo s fenotipskim presejanjem, ki predstavlja enega od učinkovitih pristopov rešetanja knjižnic spojin, želeli identificirati potencialne nove spojine s protibakterijsko aktivnostjo. Za testiranje 448 spojin smo uporabili spojine, ki so del knjižnice spojin Fakultete za farmacijo Univerze v Ljubljani, in jim z metodo minimalne inhibitorne koncentracije določili njihovo protibakterijsko aktivnost proti šestim različnim vrstam bakterij. Učinkovitost spojin smo testirali proti trem G+ bakterijam vrst Staphylococcus aureus, Enterococcus faecium in Enterococcus faecalis ter proti G– bakteriji vrste Escherichia coli in njenima dvema mutiranima sevoma, E. coli D22 in E. coli N43. Izmed vseh testiranih spojin jih je 56 (12,5 %) pokazalo biološko aktivnost. 13 spojin pa je delovalo proti več bakterijskim vrstam hkrati. Trem spojinam smo določili vrednost minimalne inhibitorne koncentracije (MIK) 15 μmol/L, ki je bila tudi najnižja določena med vsemi testiranimi vzorci spojin. Pregled strukturnih formul spojin je nakazal fragmente, ki bi bili lahko odgovorni za protibakterijsko aktivnost. Mednje prištevamo indanski obroč, prisotnost halogenih elementov ter naftalenski in 8-hidroksikinolinski sistem.

Jezik:Slovenski jezik
Ključne besede:Protibakterijske učinkovine, minimalna inhibitorna koncentracija, bakterijska odpornost, fenotipsko presejanje
Vrsta gradiva:Magistrsko delo/naloga
Tipologija:2.09 - Magistrsko delo
Organizacija:FFA - Fakulteta za farmacijo
Založnik:[L. Tadina]
Leto izida:2026
PID:20.500.12556/RUL-184418 Povezava se odpre v novem oknu
UDK:615.281:579.61(043.2)
COBISS.SI-ID:284072195 Povezava se odpre v novem oknu
Datum objave v RUL:07.07.2026
Število ogledov:100
Število prenosov:43
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Antibacterial evaluation of piperidine and pyrrolidine compound library
Izvleček:
According to estimates by the World Health Organization (WHO), the problem of antibacterial resistance in human medicine is ranked among the leading causes of death in humans. Resistance to antibiotics is mainly promoted by their incorrect and excessive use. Antibiotics that inhibit bacterial growth act bacteriostatically, while others cause the death of bacterial cells and act bactericidally. An important property of the ideal antibiotic is its selective toxicity, which means, it must inhibit only bacterial cells and not harm the host. Antibacterial drugs act according to different mechanisms of action; causing inhibition of cell wall synthesis, forming interactions with the plasma membrane, inhibition of nucleic acid synthesis, inhibition of protein synthesis and inhibition of cellular metabolism. Although several mechanisms of action of antibiotics are known, bacteria are nevertheless capable of developing resistance to them in several different ways. They can limit the antibiotic penetration into the cell, modify cell targets, inactivate the antibiotic, reduce it's concentration in the cell by efflux pumps and form biofilms. As part of the master's thesis, we used phenotypic screening, which is one of the effective approaches for screening compound libraries, to identify potential new compounds with antibacterial activity. For testing 448 compounds, we used compounds that are part of the compound library of the Faculty of Pharmacy University of Ljubljana and determined their antibacterial activity against six different types of bacteria using the minimum inhibitory concentration. The efficacy of the compounds was tested against three gram-positive bacteria, Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis, and against the gram-negative bacteria Escherichia coli and its two mutated strains, E. coli D22 and E. coli N43. Of all the tested compounds, 56 (12,5 %) showed biological activity. 13 compounds were active against multiple bacterial species simultaneously. For three compounds, we determined the minimum inhibitory concentration (MIC) value of 15 μmol/L, which was also the lowest determined among all tested compounds samples. The structural analysis of the compounds indicated fragments that could potentially be responsible for antibacterial activity. These include the indane ring, the presence of halogen atoms, and the naphthalene and 8-hydroxyquinoline systems.

Ključne besede:Antibacterial agents, minimal inhibitory concentration, bacterial resistance, phenotypic screening

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj